NCT04530318View on ClinicalTrials.gov

Dendritic Cells Therapy Combined With Immunomodulatory Treatment in Multiple Sclerosis

PHASE2RecruitingINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

January 27, 2020

Primary Completion Date

June 30, 2025

Study Completion Date

June 30, 2025

Conditions
Relapsing-Remitting Multiple Sclerosis
Interventions
OTHER

Autologous peripheral blood differentiated adult tolerogenic dendritic cells expanded

The infusion of the cells / placebo will take place at the Hospital Clínic de Barcelona (weeks 0, 2 and 4).

OTHER

Placebo

The infusion of the cells / placebo will take place at the Hospital Clínic de Barcelona (weeks 0, 2 and 4).

Trial Locations (5)

Unknown

RECRUITING

Hospital Moisés Broggi, L'Hospitalet de Llobregat

RECRUITING

Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat

RECRUITING

Hospital de Sant Pau, Barcelona

RECRUITING

Hospital del Mar, Barcelona

08036

RECRUITING

Hospital Clínic de Barcelona, Barcelona

All Listed Sponsors
lead

Judit Pich

OTHER